Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial

Background Although the development of effective and safe treatments for prophylaxis of migraine headaches represents an important public health concern, only a few medications have been approved by the specific treatment of patients with migraine. We aimed to compare the efficacy of cinnarizine wi...

Full description

Bibliographic Details
Main Authors: Zahra Alebrahim, Ali Reza Moayedi, Abdolmajid Nazemi, Abdolhossein Madani, Maryam Montaseri
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2019-01-01
Series:International Journal of Pediatrics
Subjects:
Online Access:http://ijp.mums.ac.ir/article_11435_687f5fa44addd6951c9f981db8cd793e.pdf
id doaj-23947bf5c521485eba26a9a4a9b9771d
record_format Article
spelling doaj-23947bf5c521485eba26a9a4a9b9771d2020-11-25T02:00:06ZengMashhad University of Medical SciencesInternational Journal of Pediatrics2345-50472345-50552019-01-01718907891310.22038/ijp.2018.34534.303611435Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical TrialZahra Alebrahim0Ali Reza Moayedi1Abdolmajid Nazemi2Abdolhossein Madani3Maryam Montaseri4Department of Pediatrics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.Department of Pediatrics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.Department of Pediatrics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.Background Although the development of effective and safe treatments for prophylaxis of migraine headaches represents an important public health concern, only a few medications have been approved by the specific treatment of patients with migraine. We aimed to compare the efficacy of cinnarizine with propranolol in the prophylaxis of pediatric migraine headache. Materials and Methods  In a Randomized Clinical Trial, children aged 6-14 years were selected from the patients with migraine admitted to the neurology clinic of Bandar Abbas pediatric Hospital, affiliated to Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Eligible patients (n, 56) were randomly divided into two groups, each comprising 28 patients: the first group administered cinnarizine (37.5 mg/day in children aged 6–12 years and 50 mg/day in children aged 12–17 years), and the second group received propranolol (1-mg/kg/day). The frequency, severity of headaches over the trial period were assessed.   Results: After two months of treatment, both groups had significant reduction in headache frequency in comparison with baseline period (p= 0.047), although this difference between groups was not statistically significant. In addition, the mean severe migraine attacks at the end of the second month was significantly lower in the cinnarizine group compared with the propranolol group (p=0.048).  At the end of the study 64% (n=18) of patients who had received the cinnarizine and 57% (n=16) of patients who had administered the propranolol, the drugs appeared to have a preventative effect on their headaches. Conclusion: According to the results, Cinnarizine appeared as effective as propranolol for the prophylactic treatment of childhood migraine.http://ijp.mums.ac.ir/article_11435_687f5fa44addd6951c9f981db8cd793e.pdfChildrenCinnarizineHeadacheMigrainePropranolol
collection DOAJ
language English
format Article
sources DOAJ
author Zahra Alebrahim
Ali Reza Moayedi
Abdolmajid Nazemi
Abdolhossein Madani
Maryam Montaseri
spellingShingle Zahra Alebrahim
Ali Reza Moayedi
Abdolmajid Nazemi
Abdolhossein Madani
Maryam Montaseri
Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
International Journal of Pediatrics
Children
Cinnarizine
Headache
Migraine
Propranolol
author_facet Zahra Alebrahim
Ali Reza Moayedi
Abdolmajid Nazemi
Abdolhossein Madani
Maryam Montaseri
author_sort Zahra Alebrahim
title Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
title_short Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
title_full Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
title_fullStr Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
title_full_unstemmed Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial
title_sort prophylactic efficacy of cinnarizine versus propranolol in the treatment of childhood migraine: a single-blind randomized clinical trial
publisher Mashhad University of Medical Sciences
series International Journal of Pediatrics
issn 2345-5047
2345-5055
publishDate 2019-01-01
description Background Although the development of effective and safe treatments for prophylaxis of migraine headaches represents an important public health concern, only a few medications have been approved by the specific treatment of patients with migraine. We aimed to compare the efficacy of cinnarizine with propranolol in the prophylaxis of pediatric migraine headache. Materials and Methods  In a Randomized Clinical Trial, children aged 6-14 years were selected from the patients with migraine admitted to the neurology clinic of Bandar Abbas pediatric Hospital, affiliated to Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Eligible patients (n, 56) were randomly divided into two groups, each comprising 28 patients: the first group administered cinnarizine (37.5 mg/day in children aged 6–12 years and 50 mg/day in children aged 12–17 years), and the second group received propranolol (1-mg/kg/day). The frequency, severity of headaches over the trial period were assessed.   Results: After two months of treatment, both groups had significant reduction in headache frequency in comparison with baseline period (p= 0.047), although this difference between groups was not statistically significant. In addition, the mean severe migraine attacks at the end of the second month was significantly lower in the cinnarizine group compared with the propranolol group (p=0.048).  At the end of the study 64% (n=18) of patients who had received the cinnarizine and 57% (n=16) of patients who had administered the propranolol, the drugs appeared to have a preventative effect on their headaches. Conclusion: According to the results, Cinnarizine appeared as effective as propranolol for the prophylactic treatment of childhood migraine.
topic Children
Cinnarizine
Headache
Migraine
Propranolol
url http://ijp.mums.ac.ir/article_11435_687f5fa44addd6951c9f981db8cd793e.pdf
work_keys_str_mv AT zahraalebrahim prophylacticefficacyofcinnarizineversuspropranololinthetreatmentofchildhoodmigraineasingleblindrandomizedclinicaltrial
AT alirezamoayedi prophylacticefficacyofcinnarizineversuspropranololinthetreatmentofchildhoodmigraineasingleblindrandomizedclinicaltrial
AT abdolmajidnazemi prophylacticefficacyofcinnarizineversuspropranololinthetreatmentofchildhoodmigraineasingleblindrandomizedclinicaltrial
AT abdolhosseinmadani prophylacticefficacyofcinnarizineversuspropranololinthetreatmentofchildhoodmigraineasingleblindrandomizedclinicaltrial
AT maryammontaseri prophylacticefficacyofcinnarizineversuspropranololinthetreatmentofchildhoodmigraineasingleblindrandomizedclinicaltrial
_version_ 1724962556127215616